Searched for
GLAND PHARMA IPO
Gland says not heard from its promoter Fosun about the potential saleThe debt-laden Chinese conglomerate Fosun controlled by billionaire entrepreneur Guo Guangchang has been looking to sell non-core assets, t...- Chinese-owned Gland Pharma re-appoints Srinivas Sadu as MD & CEOGland Pharma reported revenues of Rs 3463 and a net profit of Rs 997 crore in FY21. Shares of Gland Pharma rose 1.89% to close at Rs 3360 o...
- Gland Pharma in high demand ahead of listingGland Pharma shares were available at a premium of Rs 20 in the grey market during the offer subscription period between Nov 9 and 11. The ...
- Gland Pharma issue subscribed 2.06 timesGland Pharma’s initial public offer (IPO), the biggest ever offering in the Indian pharmaceutical sector — was subscribed 2.06 times on the...
- Gland Pharma’s Rs 6,480 crore IPO sails through, gets 2.06x bidsProgressive Share Brokers said that sentiment towards the IPO has dampened a bit due to Chinese investments as well as from the fact that S...
- Why is Gland Pharma citing India-China ties as key risk to IPOThe pharma company that is majority-owned by Chinese conglomerate Fosun International has noted in its filings with Sebi that it could face...
- Gland Pharma IPO receives 22% bids on Day 2Progressive Share Brokers said the sentiment towards the IPO has dampened a bit due to Chinese investments as well as from the fact that Sa...
- Gland Pharma IPO off to lacklustre start, subscribed 4% on Day 1The IPO is a mix of a fresh issue of shares worth Rs 1,250 crore and an offer for sale of up to 3.49 crore shares.
- Gland Pharma IPO: Analysts recommend subscribing, but flag stretched valuationsGland Pharma’s IPO is India’s largest pharmaceutical IPO ever.
- Gland Pharma raises Rs 1,944 crore from 70 anchor investors ahead of IPOGland Pharma has set a price band of Rs 1,490-1,500 per share for its Rs 6,500 crore IPO, which will be sold between November 9 and 11.
- Gland Pharma IPO: Issue date, price band & other key detailsThe drugmarker will likely announce the name of anchor investors by the end of Friday.
- Grey market premium fizzles out for Gland Pharma after fixing price bandThe Gland Pharma IPO, India’s largest from the pharmaceutical sector, comprises a fresh issue aggregating up to Rs 1,250 crore and an offer...
- ED directs Gland Pharma to transfer Ramalinga Raju family's 6 mn shares to escrow account"There is no risk in terms of Ramalinga Raju's shares, because they invested in the company (Gland Pharma) in the late 90s. And then they o...
- Gland Pharma IPO to open on Nov 9; price band fixed at Rs 1,490-1,500 per shareThe Gland Pharma IPO, India’s largest IPO in the pharmaceutical sector, comprises a fresh issue aggregating up to Rs 1,250 crore and an off...
- Ahead of Gland Pharma IPO, ED wants Raju family's 3.87% stake transferred to itThe development comes nearly a decade after ED ordered Gland Pharma management to attach 600,000 shares held by 10 companies belonging to R...
- Even before IPO details are out, Gland Pharma buzzing in grey marketThe pharma company is eyeing to hit the bourses with a Rs 6,000 crore issue, which will make it the biggest IPO from the Indian pharma sect...
- India's largest pharma IPO set to hit marketThis will be the largest IPO by a pharmaceutical company in India. The biggest IPO till date in the sector was from Eris Lifesciences, whic...
- Gland Pharma seeks lock-in exemption for shares owned by Ex Satyam CEO Ramanlinga RajuAs per market Sebi rules, all the pre-IPO capital needs to be locked in for a period of one year. However, it is not feasible to put the sh...
- 74% Chinese-owned Hyderabad pharma firm files for IPOThe fresh issue and the offer for sale together is expected to take the IPO size to around Rs 3,000 crore.
- Chinese firm-backed Gland Pharma files for IPO; may raise up to Rs 6,000 croreThe company may raise up to $800 million or Rs 6,000 crore, a source with the knowledge of the matter said.
Load More
